Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 9,260,000 shares, an increase of 8.8% from the October 31st total of 8,510,000 shares. Based on an average daily volume of 2,540,000 shares, the short-interest ratio is presently 3.6 days.
Analyst Upgrades and Downgrades
ASPN has been the topic of several research analyst reports. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research note on Wednesday, November 13th. TD Cowen raised their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Piper Sandler cut their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Barclays decreased their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 12th. Finally, Roth Mkm lowered their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $28.70.
Check Out Our Latest Research Report on ASPN
Aspen Aerogels Price Performance
Insider Buying and Selling at Aspen Aerogels
In related news, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. The trade was a 11.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 4.30% of the company’s stock.
Institutional Investors Weigh In On Aspen Aerogels
Large investors have recently made changes to their positions in the company. Point72 Hong Kong Ltd acquired a new stake in Aspen Aerogels during the 2nd quarter valued at $84,000. nVerses Capital LLC bought a new stake in shares of Aspen Aerogels during the second quarter worth $95,000. Quent Capital LLC acquired a new stake in shares of Aspen Aerogels in the third quarter valued at $118,000. Point72 DIFC Ltd bought a new position in shares of Aspen Aerogels in the second quarter valued at about $121,000. Finally, Public Employees Retirement Association of Colorado acquired a new position in Aspen Aerogels during the 2nd quarter worth about $145,000. Institutional investors own 97.64% of the company’s stock.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- Ride Out The Recession With These Dividend Kings
- Tesla Poised to Hit Record Highs This Holiday Season
- 3 Small Caps With Big Return Potential
- The Salesforce Rally is Just Getting Started: Here’s Why
- What is MarketRank™? How to Use it
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.